Literature DB >> 17956818

[Neonatal infections of the bones and joints].

J Sarlangue1, C Castella, J Pontailler, J F Chateil.   

Abstract

Neonatal osteoarticular infections remain rare, with an estimated incidence of 1 to 3 cases per 1000 admissions to Neonatal Intensive Care Units. It usually results from bacteraemia and may thus be induced by IV catheters. More rarely it is due to direct inoculation secondary to cutaneous damage, or extension of soft tissue infection. The particularity of bone vascularization in the newborn explains the frequency of abscess formation in the periosteum or in soft tissues. The main pathogen involved is S. aureus (3/4 of cases), followed by group B streptococci and enterobacteriacae. Infection consists mainly of localised and slowly progressing abscesses. However, multifocal and severe infection is possible, in particular when caused by an IV catheter. Ultrasonography is the best initial investigation, possibly leading to surgical care. Medical treatment must include 2 synergistic antistaphyloccocal antibiotics, possibly associated with cefotaxime. The outcome is generally favorable, but orthopaedic consequences may emerge if the growth plate is involved. Rare specific causes, such as syphilis or tuberculosis, should also be evoked, but the clinical context is generally helpful for the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17956818     DOI: 10.1016/s0929-693x(07)80044-3

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  2 in total

1.  Septic arthritis presenting as brachial plexus neurophaty.

Authors:  A Mascarenhas; C Almeida; C Constantino; A P Soudo; E Calado; J P Vieira
Journal:  BMJ Case Rep       Date:  2011-02-24

Review 2.  Pseudo paralysis of the shoulder and increased C-reactive protein are predictive factors for septic shoulder in children superior to other clinical symptoms: a retrospective case series of 25 patients.

Authors:  Cezara Danilov; Christoph Ihle; Francisco F Fernandez; Gunnar Blumenstock; Thomas Wirth; Oliver Eberhardt
Journal:  J Child Orthop       Date:  2020-02-01       Impact factor: 1.548

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.